Posted by Two Blokes
I maintain my Buy rating on Thomson Reuters, anticipating upside surprises from accretive M&As and the unlocki
Source: Two Blokes Trading
Posted by Two Blokes
Investing in biotechnology stocks is similar to the drug development process itself. That is, investors freque
Source: Two Blokes Trading
Posted by Two Blokes
SMR surges 180% YTD on tech partnerships and data center demand, but BWX Technologies' strong contracts may gi
Source: Two Blokes Trading
Posted by Two Blokes
Rithm (RITM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in it
Source: Two Blokes Trading
Posted by Two Blokes
Veralto (VLTO) possesses the right combination of the two key ingredients for a likely earnings beat in its up
Source: Two Blokes Trading
Posted by Two Blokes
TFI International (TFII) doesn't possess the right combination of the two key ingredients for a likely earning
Source: Two Blokes Trading
Posted by Two Blokes
Revvity (RVTY) possesses the right combination of the two key ingredients for a likely earnings beat in its up
Source: Two Blokes Trading
Posted by Two Blokes
Bank of Marin (BMRC) doesn't possess the right combination of the two key ingredients for a likely earnings be
Source: Two Blokes Trading
Posted by Two Blokes
NBT (NBTB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its
Source: Two Blokes Trading
Posted by Two Blokes
Merchants Bancorp (MBIN) doesn't possess the right combination of the two key ingredients for a likely earning
Source: Two Blokes Trading
Posted by Two Blokes
Sierra Bancorp (BSRR) possesses the right combination of the two key ingredients for a likely earnings beat in
Source: Two Blokes Trading
Posted by Two Blokes
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Styl
Source: Two Blokes Trading